Abstract Characterization of the genetic landscape of Alzheimer’s disease (AD) and related
dementias (ADD) provides a unique opportunity for a better understanding of the associated …

Background Frontotemporal dementia (FTD) is a complex disorder characterised by a broad
range of clinical manifestations, differential pathological signatures, and genetic variability. …

Background and objective: We explored which clinical and biochemical variables predict
conversion from clinically isolated syndrome (CIS) to clinically definite multiple sclerosis (CDMS…

Background Immunoreactivity for several chemokines and for their related receptors has
been demonstrated in resident cells of the central nervous system, and the up-regulation of …

Low frequency coding variants in TREM2 are associated with increased Alzheimer disease (AD)
risk, while loss of functions mutations in the gene lead to an autosomal recessive early-…

Triggering receptor expressed on myeloid cells 2 (TREM-2) is a membrane-bound receptor
expressed by microglia and macrophages. Engagement of TREM-2 on these cells has been …

Increasing evidence supports a role of oxidative imbalance, characterized by impaired
antioxidant enzymatic activity and increased reactive oxygen species (ROS) production, in mild …

Objective To evaluate cerebrospinal fluid ( CSF ) and serum neurofilament light chain (NfL)
levels in genetic frontotemporal dementia ( FTD ) as a potential biomarker in the …

Several micro (mi) RNA are deregulated in brain, cerebrospinal fluid (CSF), and serum/plasma
from patients with Alzheimer's disease (AD). The aim of the study was to profile …

Upregulation of a number of chemokines, including monocyte chemotactic protein-1 (MCP-1),
is associated with Alzheimer's disease (AD) pathological changes. Emerging evidence …